Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | INSM | ||
| Company | Genmab A/S ADR | Incyte Corp | Insmed Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.76 | 74.14 | 73.85 | ||
| High | 20.76 | 74.95 | 76.00 | ||
| Low | 20.46 | 73.10 | 73.52 | ||
| Last | 20.65 | 74.80 | 75.68 | ||
| Change | -0.14 | +1.28 | +1.59 | ||
| % Change | -0.67% | +1.74% | +2.15% | ||
| Volume | 1,157,900 | 1,475,600 | 1,104,400 | ||
| 20-Day Average Volume | 1,511,300 | 2,758,650 | 1,723,615 | ||
| Previous Close | 20.79 | 73.52 | 74.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 21.74 | 76.45 | 71.06 | ||
| 20-Day Raw Stochastic | 9.90% | 51.66% | 93.28% | ||
| 20-Day Relative Strength | 31.52% | 54.81% | 56.30% | ||
| Weighted Alpha | -38.68 | +40.77 | +37.69 | ||
| Today's Opinion | 100% Sell | 80% Buy | 48% Buy | ||
| Previous Opinion | 100% Sell | 80% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.73% since 11/19/24 | +6.01% since 11/19/24 | +2.66% since 11/19/24 | ||
| Low | 20.34 on 11/21/24 | 69.30 on 11/21/24 | 70.93 on 11/21/24 | ||
| High | 20.98 on 11/25/24 | 74.95 on 11/26/24 | 76.46 on 11/25/24 | ||
| 1-Month | |||||
| %Chg | -10.68% since 10/25/24 | +14.95% since 10/25/24 | +6.65% since 10/25/24 | ||
| Low | 20.34 on 11/21/24 | 64.86 on 10/28/24 | 64.86 on 11/18/24 | ||
| High | 23.47 on 11/11/24 | 83.95 on 11/08/24 | 76.46 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | -24.52% since 08/26/24 | +14.79% since 08/26/24 | +0.62% since 08/26/24 | ||
| Low | 20.34 on 11/21/24 | 61.15 on 09/05/24 | 64.86 on 11/18/24 | ||
| High | 27.94 on 08/27/24 | 83.95 on 11/08/24 | 78.24 on 08/29/24 | ||
| 6-Month | |||||
| %Chg | -26.25% since 05/24/24 | +30.52% since 05/24/24 | +244.00% since 05/24/24 | ||
| Low | 20.34 on 11/21/24 | 56.41 on 05/29/24 | 44.51 on 05/28/24 | ||
| High | 28.96 on 06/05/24 | 83.95 on 11/08/24 | 80.53 on 08/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,665,509 | 13,816,858 | 13,086,754 | ||
| Shares Outstanding, K | 661,768 | 192,650 | 178,903 | ||
| Annual Sales | 2,392,030,000 | 3,695,650,000 | 305,210,000 | ||
| Annual Net Income | 631,910,000 | 597,600,000 | -749,570,000 | ||
| Last Quarter Sales | 816,600,000 | 1,137,870,000 | 93,430,000 | ||
| Last Quarter Net Income | 186,610,000 | 106,460,000 | -220,520,000 | ||
| 60-Month Beta | 0.99 | 0.71 | 1.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 11/06/24 | 1.07 on 10/29/24 | -1.27 on 10/31/24 | ||
| Latest Earnings Date | 11/06/24 | 10/29/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 19.87 | 0.00 | 0.00 | ||